PMCPA Case Library

Over 2,000+ real adjudications. Browse free — subscribe to search by company, clause and case reference.

Search by company, clause, case ref…🔒
Filter by clause…🔒
Filter by company…🔒

1,914 cases  ·  Unlock search, clause & company filters ↓

2007
year
AUTH/2012/6/07 Takeda Clause 2 Clause 7.2 Clause 7.3

GSK v Takeda: Competact mailer cost claim ruled misleading after Drug Tariff change (AUTH/2012/6/07)

Takeda’s Competact mailer claimed it was uniquely cheaper than its constituent parts. After a January Drug Tariff change, Avandamet was…

2019
year
AUTH/3178/3/19 GlaxoSmithKline Clause 4.1 Clause 4.4 Clause 9.1 ⭐ Case of the Week

GSK webinar registration page held to promote Relvar Ellipta without prescribing information (AUTH/3178/3/19)

GSK’s HCP webinar registration page about fluticasone furoate was deemed promotional for Relvar Ellipta but omitted prescribing information. Breach of…

2006
year
AUTH/1907/10/06 Ivax Pharmaceuticals UK Clause 7.10 Clause 7.2 Clause 7.4

Galen v Ivax: Mucodyne ads found misleading for relying on Allegra et al (Fluifort) data

Ivax cited an Italian carbocysteine lysine study (Fluifort) to support Mucodyne COPD claims. The Panel said the products/dosing weren’t shown…

2006
year
AUTH/1839/5/06 Merck Sharp & Dohme Clause 9

Merck Sharp & Dohme: Univadis mailing sent after unsubscribe request and envelope not marked confidential (AUTH/1839/5/06)

A GP received a Univadis mailing containing username/password in an envelope not marked confidential, despite asking to deregister. Panel found…

2010
year
AUTH/2339/7/10 Novo Nordisk

Anonymous Diabetes Specialist Nurse v Novo Nordisk (AUTH/2339/7/10) – Daily Telegraph articles about Victoza

Complaint about Daily Telegraph articles referencing Victoza. PMCPA found the matter outwith the scope of the ABPI Code; no breach…

2011
year
AUTH/2447/10/11 Eli Lilly

Anonymous v Lilly (AUTH/2447/10/11): Alleged promotion of Cialis – no case report (outwith scope)

Complaint about alleged promotion of Cialis. PMCPA recorded no breach because the matter was outwith the scope of the Code;…

2018
year
AUTH/3057/8/18 Novo Nordisk ⭐ Case of the Week

AUTH/3057/8/18: CCG employee v Novo Nordisk (Victoza) — no breach over alleged handwritten eGFR claim

CCG alleged a Novo Nordisk rep asked a receptionist to add a handwritten Victoza claim about use at eGFR <15.…

2019
year
AUTH/3149/1/19 Endo Ventures Clause 3.2 Clause 9.1

Endo Ventures breached ABPI Code over fluoxetine ad claim “for treatment of depressive illness” (AUTH/3149/1/19)

A Pulse ad for fluoxetine used the broad claim “for treatment of depressive illness”. PMCPA ruled it didn’t accurately reflect…

2019
year
AUTH/3224/7/19 Vifor Pharma

AUTH/3224/7/19: Vifor misleading comparative safety claims for Ferinject vs Monofer and misused “medical information” response

Vifor’s reps used materials implying Ferinject had fewer ADRs than Monofer. A follow-up “medical information” email was ruled promotional, misleading…

2019
year
AUTH/3276/10/19 Ipsen Clause 26.1 Clause 26.2 Clause 9.1

Ipsen: Global LinkedIn post linking to ENGAGE press release ruled public promotion of Dysport (AUTH/3276/10/19)

A global Ipsen LinkedIn post featuring a UK-based employee quote linked to an ENGAGE study press release. PMCPA said this…

2019
year
AUTH/3213/6/19 Janssen

AUTH/3213/6/19: Anonymous v Janssen — alleged off-licence promotion at prostate cancer summit (No breach)

Anonymous complaint alleged off-licence, misleading and disguised promotion at a Janssen-sponsored oncology meeting. Panel ruled no breach as allegations lacked…

2020
year
AUTH/3367/7/20 GlaxoSmithKline ⭐ Case of the Week

GSK Duac banner ad on Pulse Today: complaint about missing prescribing information (AUTH/3367/7/20) – No breach

A UK health professional said a Duac 5% Pulse Today banner was static and lacked prescribing info. GSK said it…

2019
year
AUTH/3188/4/19 Bayer Clause 9.1

Anonymous v Bayer (AUTH/3188/4/19): Third-party email linked Xarelto to sponsored anticoagulation therapy review service

Complaint about a third-party provider’s internal email linking Bayer’s AF therapy review service to Xarelto. Panel found breach of Clause…

2020
year
AUTH/3299/1/20 Novo Nordisk Clause 15.1 Clause 15.9 Clause 2

Novo Nordisk breached ABPI Code over Saxenda materials at fertility conference lacking prominent pregnancy warnings (AUTH/3299/1/20)

At a fertility conference, Saxenda materials and patient brochure lacked clear, prominent pregnancy/trying-to-conceive warnings. Appeal Board found misleading safety presentation,…

2020
year
AUTH/3370/8/20 Ferring Pharmaceuticals Clause 14 Clause 9

Ferring: Uncertified Nocdurna supplement remained accessible online years after intended withdrawal (AUTH/3370/8/20)

A Ferring-sponsored nocturia supplement with UK Nocdurna prescribing info stayed accessible online for 2.5+ years beyond its Dec 2017 end…

2020
year
AUTH/3398/10/20 Merck Sharp & Dohme Clause 26.1 Clause 9.1

MSD voluntary admission: Steglatro formulary guide visible to the public due to transparent journal wrappers (AUTH/3398/10/20)

A Steglatro formulary decision guide intended for HCPs was visible through transparent wrappers used for some mailed journals. MSD admitted…

2020
year
AUTH/3417/11/20 Daiichi-Sankyo UK Clause 22.4 Clause 9.1 Clause 9.10 ⭐ Case of the Week

Daiichi-Sankyo: sponsorship disclosure in third-party YouTube meeting recording (Lixiana) found unclear from the outset

A patient complained about a YouTube-hosted meeting recording mentioning Lixiana. Most allegations were not upheld, but Daiichi-Sankyo was found in…

2020
year
AUTH/3439/12/20 Amgen Clause 9

Amgen disease awareness newspaper ad ruled misleading due to “flu jab alongside your osteoporosis medicine” wording (AUTH/3439/12/20)

A national newspaper osteoporosis awareness ad “supported by Amgen” was not POM promotion, but was ruled misleading for implying patients…

2021
year
AUTH/3500/4/21 Sanofi

AUTH/3500/4/21: Employee complaint about representative training at Sanofi (No breach)

Anonymous employee alleged poor diabetes rep training and over-reliance on a fellow representative. Panel found complaint unproven on balance of…

2021
year
AUTH/3505/4/21 Britannia

AUTH/3505/4/21: Complainant v Britannia — advisory boards and nursing service (No breach)

Anonymous ex-employee alleged Lecigon advisory boards were marketing-led/disguised promotion and that a nursing service was compromised by sales access to…

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Filter by any clause or company

Members can instantly filter all 2,000+ cases by any of the 154 PMCPA clauses and 291 pharmaceutical companies — plus get video walkthroughs, expert podcasts and CPD certificates for every case.

154
Clauses to filter by
291
Companies to filter by
2,000+
Searchable cases
See plans from £299/year Sign in
⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week — free.

Subscribe Free
🎓 AQP Training